Korea, Republic of vs Tuvalu: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Korea, Republic of
97.0%
in 2025
Tuvalu
97.0%
in 2025
Korea, Republic of rank
16th
Tuvalu rank
16th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Korea, Republic of
- Tuvalu
How they compare
Korea, Republic of currently reports 97.0% against 97.0% in Tuvalu, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tuvalu ahead.
Korea, Republic of ranks 16th and Tuvalu ranks 16th of 192 countries.
Korea, Republic of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Korea, Republic of | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 48.7% | 0.0% | 48.7% | Korea, Republic of |
| 2020s | 97.0% | 62.5% | 34.5% | Korea, Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Korea, Republic of or Tuvalu?
- Korea, Republic of, at 97.0% against 97.0% in Tuvalu as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Korea, Republic of and Tuvalu?
- 0.0%, with Korea, Republic of ahead.
- How many years of comparable data are there for Korea, Republic of and Tuvalu?
- 18 years are reported by both, from 2008 to 2025.
- How do Korea, Republic of and Tuvalu rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Korea, Republic of ranks 16th and Tuvalu ranks 16th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.